N 6 ‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases
Immunity, Inflammation and Disease · 2024-12 · 12 (12)
DOI: 10.1002/iid3.70089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 11.12.2024. Verfasst von Xiangrong Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The affiliated Children's Hospital of Shanxi Medical University, Children's Hospital of Shanxi, Shanxi Maternal and Chi…. Hauptthemen laut MEDLINE: Adenosine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by National Natural Science Foundation of China (grant no. 82000722 and 82000302), Natural Science Foundation of Shanxi (grant no. 201….
Abstract (Originalsprache)
Background
N6‐methyladenosine (m6A) modification is a widespread and reversible epigenetic alteration in eukaryotic mRNA, playing a pivotal role in various biological functions. Its significance in female reproductive development and associated diseases has recently become a focal point of research.
Objective
This review aims to consolidate current knowledge of the role of m6A modification in female reproductive tissues, emphasizing its regulatory dynamics, functional significance, and implications in reproductive health and disease.
Methods
A comprehensive analysis of recent studies focusing on m6A modification in ovarian development, oocyte maturation, embryo development, and the pathogenesis of reproductive diseases. Results m6A modification exhibits dynamic regulation in female reproductive tissues, influencing key developmental stages and processes. It plays critical roles in ovarian development, oocyte maturation, and embryo development, underpinning essential aspects of reproductive health. m6A modification is intricately involved in the pathogenesis of several reproductive diseases, including polycystic ovary syndrome (PCOS), premature ovarian failure (POF), and endometriosis, offering insights into potential molecular mechanisms and therapeutic targets.
Conclusion
The review highlights the crucial role of m6A modification in female reproductive development and related diseases. It underscores the need for further research to explore innovative diagnostic and therapeutic strategies for reproductive disorders, leveraging the insights gained from understanding m6A modification's impact on reproductive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, The affiliated Children's Hospital of Shanxi Medical University, Children's Hospital of Shanxi, Shanxi Maternal and Child Health Hospital, Taiyuan, China.
- Department of Clinical Laboratory, Shanxi Provincial People's Hospital, Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Xiangrong Cui, Xuan Jing
Förderung
- This study was supported by National Natural Science Foundation of China (grant no. 82000722 and 82000302), Natural Science Foundation of Shanxi (grant no. 201…
Zitieren
APA
Cui, X., Li, H., Huang, X., Xue, T., Wang, S., Zhu, X., & Jing, X. (2024). N 6 ‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases. Immunity, Inflammation and Disease, 12(12). https://doi.org/10.1002/iid3.70089
Vancouver
Cui X, Li H, Huang X, Xue T, Wang S, Zhu X, et al. N 6 ‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases. Immunity, Inflammation and Disease. 2024;12(12). doi:10.1002/iid3.70089
BibTeX
@article{Cui2024,
author = {Cui, Xiangrong and Li, Huihui and Huang, Xia and Xue, Tingting and Wang, Shu and Zhu, Xinyu and Jing, Xuan},
title = {N 6 ‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {12},
doi = {10.1002/iid3.70089}
}
EUVIMED